Rare diseases
Investigational molecules
Locations
Back to Germany689 clinical trials in Bad Krozingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer
GermanyStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
GermanyStudy on Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed, Refractory, or Newly Diagnosed Multiple Myeloma
GermanyStudy on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials
GermanyStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
GermanyStudy on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis
GermanyStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
GermanyStudy of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History
GermanyStudy on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss
GermanyStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
GermanyStudy on Bevacizumab for Patients with Newly Diagnosed IDH Wild-Type, MGMT Unmethylated Glioblastoma
GermanyStudy Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lipoprotein management and preventive therapies for cardiovascular disease, exploring new treatments to reduce major cardiovascular events in high-risk patients.
Advanced studies evaluating novel therapeutic approaches for better cardiovascular outcomes.
Clinical investigations into deep vein thrombosis treatments and prevention of systemic embolism, particularly in patients with atrial fibrillation.
Comprehensive research on blood clot prevention and treatment methodologies.
Studies addressing hypertension management and innovative treatments for acute coronary syndromes, including specialized interventions for heart attack prevention.
Evaluating cutting-edge therapies for various cardiac conditions.
Research focusing on peripheral arterial disease and advanced vascular interventions, including novel contrast medium strategies for better patient outcomes.
Developing safer and more effective vascular treatment approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
